Skip to main content
Caplight Logo









Sigma Genetics

Sigma Genetics

Private
Seattle, WashingtonHealthcare & Life Scienceshttps://sigmagenetics.com/

Last Round

Seed

May 7, 2026

Est. Valuation

$1.71M

Total Funding Raised

$3.74M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Sigma Genetics is a biotechnology company that develops gene delivery platforms, including the Magnetoporator™ device, to enable scalable and high-efficiency cell engineering for drug discovery and therapeutic manufacturing.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Biotech Equipment, Medical Devices

Business Model

B2B

Customer Profile

Services & Consulting, Hardware Sales

AI Layer

Non-AI

Keywords

gene deliverymagnetoporationcell therapytransfectionbioprocessingcell engineeringbiotech equipmentintracellular deliveryclinical manufacturingbiomanufacturinglab automationnon-viral deliveryCDMObiotech hardwaredefense biotech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Sigma Genetics Comparables

Compare Sigma Genetics with similar companies based on industry and business-model similarity.

Sigma Genetics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Kytopen
79%
CellFE
79%
Celetrix
78%

Sigma Genetics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedMay 7, 2026
AcceleratorMar 23, 2026
GrantAug 8, 2023
SeedJan 27, 2022
AcceleratorMar 1, 2017

Key People

Founding team and executive leadership

Zachary R.

Co-Founder & CEO

Founding Team

Sigma Genetics Investors

Notable investors and investment history

Sigma Genetics investors
InvestorRounds
Plug and Play Tech CenterAccelerator
Capital FactorySeed
Asymmetry VenturesSeed
Y CombinatorAccelerator, Seed
Healthspan CapitalSeed
AFVenturesGrant
Biosphere Investment GroupSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 19, 2026

    Monthly visitors increased 46% month-over-month.

  • Aug 8, 2023

    Secured $1.73M in grant funding from AFVentures and Andy Hill Cancer Research Endowment Fund.

Sigma Genetics Filings

Explore SEC and related filing metadata, where available.

Sigma Genetics filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Sigma Genetics's valuation, stock price, and market status.

Is Sigma Genetics a public or private company?

Sigma Genetics is a private company.

What is the current stock price of Sigma Genetics?

Sigma Genetics is a private company with no public stock price. No recent secondary market data is available.

How much is Sigma Genetics worth (valuation)?

Valuation information for Sigma Genetics is not publicly available.

Can I buy Sigma Genetics stock?

Sigma Genetics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Sigma Genetics's last funding round?

Sigma Genetics's most recent funding round was Seed on January 27, 2022.

Who are the main investors in Sigma Genetics?

Key investors in Sigma Genetics include Capital Factory, Asymmetry Ventures, Healthspan Capital, Biosphere Investment Group.

Will Sigma Genetics IPO soon?

No public IPO plans have been announced for Sigma Genetics.

How can I track Sigma Genetics secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Sigma Genetics's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersSeattle, Washington
Employee Range6
Year Founded2016
Last FundingMay 7, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?